NCI - Center for Cancer Research

Bethesda, Maryland 20892

We've found

4 trials

at this facility

Atezolizumab in Treating Patients With Newly Diagnosed and Metastatic Alveolar Soft Part Sarcoma That Cannot Be Removed by Surgery

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Bethesda, MD

Cabozantinib-s-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Bethesda, MD

Olaparib in Treating Patients With Metastatic or Advanced Urothelial Cancer With DNA-Repair Defects

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Bethesda, MD

Birinapant and Intensity Modulated Re-Irradiation Therapy in Treating Patients With Locally Recurrent Head and Neck Squamous Cell Carcinoma

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Bethesda, MD

Use our guide to learn which trials are right for you!